---
title: "Wedbush Keeps Their Buy Rating on Prime Medicine, Inc. (PRME)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285757917.md"
description: "In a report released today, from Wedbush maintained a Buy rating on Prime Medicine, Inc., with a price target of $8.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks In addition to Wedbush, Prime Medicine, Inc. also received a Buy from TD Cowen’s Joseph Thome in a report issued yesterday. However, today, H.C. Wainwright reiterated a Hold rating on Prime Medicine, Inc. (NASDAQ: PRME)."
datetime: "2026-05-08T17:15:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285757917.md)
  - [en](https://longbridge.com/en/news/285757917.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285757917.md)
---

# Wedbush Keeps Their Buy Rating on Prime Medicine, Inc. (PRME)

In a report released today, from Wedbush maintained a Buy rating on Prime Medicine, Inc., with a price target of $8.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

In addition to Wedbush, Prime Medicine, Inc. also received a Buy from TD Cowen’s Joseph Thome in a report issued yesterday. However, today, H.C. Wainwright reiterated a Hold rating on Prime Medicine, Inc. (NASDAQ: PRME).

### Related Stocks

- [PRME.US](https://longbridge.com/en/quote/PRME.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [BeOne Medicines: Recent FDA Approval Rewrites One-Drug Narrative](https://longbridge.com/en/news/287245995.md)
- [BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News](https://longbridge.com/en/news/287198763.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO](https://longbridge.com/en/news/287276384.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)